Monday, April 28, 2025

Latest

Green Thumb: Analyst Consensus Estimates For Q3 2021

Green Thumb Industries (CSE: GTII) announced that they will be reporting their third quarter financials after the markets close on November 10th.

Analysts have a consensus C$59.06 12-month price target on the company, via a total of 16 analysts, with 4 analysts having strong buy ratings, and the other 12 having buy ratings on the company. The street high comes from Stifel-GMP with an C$80 price target, and the lowest target comes from Roth Capital Partners with a C$40 price target.

15 analysts have revenue estimates for the third quarter. The mean between all 15 is US$233.33 million; this number has been revised slightly upwards from US$221.54 million at the start of May. The street high is US$250.60 million while the lowest sits at US$222.27 million.

Six analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 55.32%, with this number being flat at the start of May. Street high is 57% estimate and the lowest sits at 54%.

Onto EBITDA estimates, there are currently 14 analysts who have third-quarter EBITDA estimates. The mean is currently US$82.54 million, with this number being basically flat since the start of May. Street high sits at US$88.70 million EBITDA and the lowest being a US$78.23 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Bell Q3 Earnings: Massive Impairments. Guidance Cuts. A Mess.

Alamos Gold Q3: Record Revenue & Production Amid Rising Costs

The Junior Mining Market Is Back

Recommended

Germany Looks To Modernize Military Recruitment But Stops Short of Conscription

First Majestic Silver Posts Topline Revenue Of $146.1 Million In Q3 2024

Related News

MicroStrategy: Canaccord Lowers Price Target To $780

MicroStrategy (NASDAQ: MSTR) reported its second quarter financial results on July 29. The company reported...

Tuesday, August 3, 2021, 11:35:00 AM

Mind Medicine: Canaccord Maintains Ratings Following Financial Results

On Friday, November 13th, Mind Medicine (NEO: MMED) reported their third quarter 2020 financial results....

Tuesday, November 17, 2020, 10:17:00 AM

Patriot One Sees Canaccord Reduce Price Target To $0.75 Following Delays

Thursday, Canaccord Genuity’s Doug Taylor lowered Patriot One’s (TSX: PAT) 12-month price target from C$1.15...

Saturday, October 17, 2020, 01:42:00 PM

GameStop: Analyst Expectations For GME’s Fourth Quarter

GameStop (NYSE: GME) announced that they will be reporting their fourth quarter and year-end financials...

Tuesday, March 23, 2021, 02:33:16 PM

Curaleaf: Cormark Upgrades To Buy Rating, Canaccord, Haywood Raise Price Targets

After Curaleaf’s (CSE: CURA) record-breaking second-quarter numbers, analysts have upgraded their twelve-month price targets. Curaleaf...

Wednesday, August 19, 2020, 11:29:55 AM